Sugi Predict

Sugi Predict / Compounds / SCHEMBL369476

SCHEMBL369476

SCHEMBL369476

Cc1ccnc(Nc2nc(-c3c[nH]nc3C(O)c3ccccc3)cs2)n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 15/20 0.42
▸ RAB9A P51151 15/20 0.42
▸ MEN1 O00255 14/20 0.42
▸ KMT2A Q03164 14/20 0.42
▸ SENP8 Q96LD8 2/20 0.42
▸ SENP7 Q9BQF6 2/20 0.42
▸ SENP6 Q9GZR1 2/20 0.42
▸ SMN1; SMN2 Q16637 10/20 0.41
▸ MAPT P10636 7/20 0.41
▸ ATM Q13315 2/20 0.41
▸ PKM P14618 1/20 0.41
▸ ALDH1A1 P00352 5/20 0.40
▸ POLB P06746 5/20 0.40
▸ NFKB1 P19838 3/20 0.40
▸ NFKB2 Q00653 3/20 0.40
▸ RELA Q04206 3/20 0.40
▸ TYR P14679 2/20 0.40
▸ TRPV4 Q9HBA0 1/20 0.38
▸ TDP1 Q9NUW8 2/20 0.37
▸ TP53 P04637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL370601 0.84 MEN1 (0.43) NPC1RAB9AMEN1KMT2ASENP8
SCHEMBL370036 0.82 RAB9A (0.52) NPC1RAB9AMEN1KMT2ASENP8
SCHEMBL369668 0.79 NPC1 (0.42) NPC1RAB9AMEN1KMT2ASENP8
SCHEMBL369982 0.78 KMT2A (0.49) NPC1RAB9AMEN1KMT2ASENP8
SCHEMBL370966 0.78 GRM4 (0.45) NPC1RAB9AMEN1KMT2ASENP8
SCHEMBL2538671 0.78 NPC1 (0.44) NPC1RAB9AMEN1KMT2ASENP8
SCHEMBL369387 0.77 GRM4 (0.38) NPC1RAB9AMEN1KMT2ASENP8
SCHEMBL15166813 0.77 MEN1 (0.50) NPC1RAB9AMEN1KMT2ASENP8
SCHEMBL12482631 0.77 VCP (0.43) NPC1RAB9AMEN1KMT2ASENP8
SCHEMBL368784 0.77 NPC1 (0.44) NPC1RAB9AMEN1KMT2ASENP8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130210809-A1 NOVEL 2-AMINO-4-PYRAZOLYL-THIAZOLE DERIVATIVES AND THEIR USE AS ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS BOLEA CHRISTELLE (CH) 2013-08-15 — — US claimed
EP-2595986-A2 NOVEL 2-AMINO-4-PYRAZOLYL-THIAZOLE DERIVATIVES AND THEIR USE AS ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS Addex Pharma SA (CH) 2013-05-29 — — EP claimed
WO-2012009009-A2 NOVEL 2-AMINO-4-PYRAZOLYL-THIAZOLE DERIVATIVES AND THEIR USE AS ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS ADDEX PHARMA S.A. (CH) 2012-01-19 — — WO claimed
US-20130210809-A1 NOVEL 2-AMINO-4-PYRAZOLYL-THIAZOLE DERIVATIVES AND THEIR USE AS ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS BOLEA CHRISTELLE (CH) 2013-08-15 — — US disclosed
EP-2595986-A2 NOVEL 2-AMINO-4-PYRAZOLYL-THIAZOLE DERIVATIVES AND THEIR USE AS ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS Addex Pharma SA (CH) 2013-05-29 — — EP disclosed
WO-2012009009-A2 NOVEL 2-AMINO-4-PYRAZOLYL-THIAZOLE DERIVATIVES AND THEIR USE AS ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS ADDEX PHARMA S.A. (CH) 2012-01-19 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130210809-A1 NOVEL 2-AMINO-4-PYRAZOLYL-THIAZOLE DERIVATIVES AND THEIR USE AS ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS GRM2, GRM4, GRM1 NPC1 1289/4885RAB9A 2094/4885MEN1 4364/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.